Upgrade to Finviz Elite: Get our fastest platform speed, real-time data, and unlimited screening & charting. Start Free Trial

AKTX

Akari Therapeutics Plc ADR

May 22 • 04:00PM ET

18.27

+13.13 255.45 %

Healthcare • Biotechnology • USA • Nano • NASD

Peers: MREO LRMR OCGN BDTX VNDA

Scroll to Statements

Index	-	P/E	-	EPS (ttm)	-18.86	Insider Own	0.40%	Shs Outstand	1.14M	Perf Week	423.50%
Market Cap	20.83M	Forward P/E	-	EPS next Y	-4.68	Insider Trans	0.00%	Shs Float	1.14M	Perf Month	204.50%
Enterprise Value	18.73M	PEG	-	EPS next Q	-1.33	Inst Own	5.91%	Short Float	1.42%	Perf Quarter	87.96%
Income	-28.00M	P/S	-	EPS this Y	72.10%	Inst Trans	-39.16%	Short Ratio	0.12	Perf Half Y	-8.41%
Sales	0.00M	P/B	1.45	EPS next Y	18.89%	ROA	-66.00%	Short Interest	0.02M	Perf YTD	58.04%
Book/sh	12.56	P/C	7.36	EPS next 5Y	32.82%	ROE	-155.01%	52W High	56.80 -67.83%	Perf Year	-63.60%
Cash/sh	2.48	P/FCF	-	EPS past 3/5Y	- -	ROIC	-194.71%	52W Low	3.02 505.97%	Perf 3Y	-88.75%
Dividend Est.	-	EV/EBITDA	-	Sales past 3/5Y	- -	Gross Margin	-	Volatility	45.58% 23.80%	Perf 5Y	-98.76%
Dividend TTM	-	EV/Sales	-	EPS Y/Y TTM	13.85%	Oper. Margin	-	ATR (14)	1.76	Perf 10Y	-99.84%
Dividend Ex-Date	-	Quick Ratio	0.27	Sales Y/Y TTM	-	Profit Margin	-	RSI (14)	84.22	Recom	2.00
Dividend Gr. 3/5Y	- -	Current Ratio	0.27	EPS Q/Q	-75.83%	SMA20	231.22%	Beta	0.65	Target Price	33.50
Payout	-	Debt/Eq	0.05	Sales Q/Q	-	SMA50	234.49%	Rel Volume	250.20	Prev Close	5.14
Employees	6	LT Debt/Eq	0.00	Earnings	Apr 07	SMA200	1.62%	Avg Volume	133.54K	Price	18.27
IPO	May 07, 2013	Option/Short	No / No	EPS/Sales Surpr.	-66.11% -	Trades		Volume	33,411,338	Change	255.45%

Affiliate • Advertise • Careers • Contact • Blog • Help • Privacy • Follow us on X • Do Not Sell My Personal Information

Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
Copyright © 2007-2026 Finviz.com. All Rights Reserved. Export All Screener Data (CSV)